Search for a trial

Open label, non-randomized, non-placebo controlled Phase 1 study to investigate the mass balance, pharmacokinetics and metabolic disposition of [14C]BAY 3283142 in healthy male participants.

To determine the mass balance and routes of excretion of total radioactivity after a single oral 10 mg dose of [14C]BAY 3283142 given as a solution. To quantify total radioactivity in plasma and whole blood